Cannabis Shows Little Benefit for Most Mental Disorders, Data Review Finds
A recent data review shows cannabis use for mental disorders has limited evidence supporting its benefits. Clinicians should be cautious when considering cannabis for psychiatric treatment. The findings highlight the need for more rigorous research on…
Massachusetts Survey Reveals Cannabis Mental Health Risks Gap
A Massachusetts survey highlights a significant gap in public awareness about massachusetts cannabis mental health risks. Many residents do not recognize the link between cannabis use and conditions like anxiety, depression, and psychosis. This lack of…
In the Mix: 6 More Articles — March 16, 2026
Cannabis legalization spurs innovation across regulatory and clinical domains. This article reviews recent developments impacting public health and law enforcement. Clinicians must navigate these changes with evidence-based guidance.
Cannabis for Pets? Maryland Vets Could Soon Recommend It
How cannabis transforms animal medicine is an emerging topic as Maryland vets could soon recommend cannabis products for pets. This change parallels human medical cannabis use and raises important clinical considerations. Understanding veterinary…
Avicanna Sponsoring THC Dose Finding Clinical Trial at University of Calgary
Avicanna is sponsoring a THC dosing anxiety clinical trial at the University of Calgary to investigate optimal oral THC doses for anxiety and stress. This clinical trial aims to provide evidence-based dosing guidance for THC in anxiety disorders. Results…
Exploring CBD Anxiolytic Benefits in Anxiety Management
CBD anxiolytic benefits have been shown to reduce anxiety symptoms in clinical studies. Cannabis products containing CBD provide meaningful anxiety relief. This page explores the role of CBD in anxiety management.
Avicanna Supports University of Calgary Trial on Oral THC Dosing for Anxiety
This article covers oral THC dosing anxiety research sponsored by Avicanna at the University of Calgary. The clinical trial aims to establish safe and effective oral THC dosing guidelines for anxiety treatment. Understanding dose-dependent effects is…
Is Medicare Turning Seniors Into CBD Test Subjects? – Newswire
Medicare CBD use seniors is a growing concern due to unregulated products and lack of clinical oversight. Older adults self-treat with CBD for pain, anxiety, and sleep without standardized dosing. This raises safety and drug interaction risks that…
Cannabinoids & Athlete Mental Health: Clinical Evidence
Retired professional athletes face unique mental health challenges, including depression and anxiety. Cannabinoid clinical trials athlete mental health research explores potential therapeutic roles. Understanding this evidence helps guide clinical…
Michigan Cannabis Licenses Decline as Industry Shakeout Forces Growers and Dispensaries to Exit
Michigan cannabis industry consolidation is driving a decline in active licenses as growers and dispensaries exit the market. This shakeout affects product availability and patient access. Clinicians should monitor these changes to advise patients…